Among patients with iRBD, altered visuospatial cue-elicited N2 and P3 ERPs predicted phenoconversion to α-synucleinopathies.
A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...
FODMAP Everyday® on MSN21h
Alzheimer's Vs. Dementia: The Key Differences You Need To KnowMany people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...
It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...
The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
More about lecanemab More about donanemab When people can be diagnosed in the earlier stages of dementia and access new disease-modifying treatments, the typical pattern of decline experienced by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback